Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VOTIVE: SUBLOCADE for Opioid Overdose
NCT03818399Phase 3Terminated
- Sponsor
- Virginia Commonwealth University
- Start
- Jan 2019
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine extended-release injection in opioid use disorder (OUD), sponsored by Virginia Commonwealth University. Started Jan 2019; status: terminated.
02
Drugs
buprenorphine extended-release injection
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03818399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03818399.